drugset / Trial / NCT07039045
A Study of [14C]-LY4065967 in Healthy Participants
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to investigate the absorption, metabolism, excretion, and bioavailability of LY4065967 in healthy male participants. This is a 2-part study. The study will last about 58 days for participants in Part 1 and about 60 days for participants in Part 2.
Timeline
- Start
- 2025-06-23
- Primary completion
- 2025-08-16
- Completion
- 2025-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY4065967 | Unknown | — | Oral |
Indications
No indication recorded.